StockData
TuHURA Biosciences, Inc./NV logo

TuHURA Biosciences, Inc./NV (HURA) stock

HURANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$1.36−0.01 (-0.73%)

Close on Nov 19, 2026Market cap $86.67MP/E –Yield –

TuHURA Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

No price to sales ratio figures for TuHURA Biosciences

TuHURA Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More TuHURA Biosciences figures

See a number that looks wrong?